Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross Jeggo

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Protocols in Pharmacology|September 8, 2015
Electrophysiological Techniques for Studying Synaptic Activity In VivoRoss Jeggo, Fei-Yue Zhao, David Spanswick
Current Protocols in Pharmacology|September 3, 2014
In vivo electrophysiological recording techniques for the study of neuropathic pain in rodent modelsFei-Yue Zhao, Ross Jeggo, Haifeng Wei, et al.
Eneuro|November 6, 2019
Long-Term Exposure to PFE-360 in the AAV-α-Synuclein Rat Model: Findings and ImplicationsMichael Aagaard Andersen, Florence Sotty, Poul Henning Jensen, et al.
Neurobiology of Disease|April 23, 2018
Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulationMichael Aagaard Andersen, Kenneth Vielsted Christensen, Lassina Badolo, et al.
British Journal of Pharmacology|January 17, 2016
Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivoFilippo Andreetta, Lucia Carboni, Gillian Grafton, et al.
Journal of Neurophysiology|September 23, 2016
α7-nAChR agonist enhances neural plasticity in the hippocampus via a GABAergic circuitMatthew Townsend, Andrew Whyment, Jean-Sebastien Walczak, et al.
Psychopharmacology|June 8, 2011
Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576Roberta Bursi, Gul Erdemli, Robert Campbell, et al.
The International Journal of Neuropsychopharmacology|October 10, 2013
Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer's diseaseEugene O'Hare, David I C Scopes, Eun-Mee Kim, et al.
Toxicology|January 9, 2018
PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in ratsMichael Aagaard Andersen, Karen Malene Wegener, Steen Larsen, et al.
Acta Neuropathologica Communications|November 3, 2021
P62 accumulates through neuroanatomical circuits in response to tauopathy propagationFrançois-Xavier Blaudin de Thé, Benjamin Lassus, Ari W Schaler, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Protocols in Pharmacology|September 8, 2015
Electrophysiological Techniques for Studying Synaptic Activity In VivoRoss Jeggo, Fei-Yue Zhao, David Spanswick
Current Protocols in Pharmacology|September 3, 2014
In vivo electrophysiological recording techniques for the study of neuropathic pain in rodent modelsFei-Yue Zhao, Ross Jeggo, Haifeng Wei, et al.
Eneuro|November 6, 2019
Long-Term Exposure to PFE-360 in the AAV-α-Synuclein Rat Model: Findings and ImplicationsMichael Aagaard Andersen, Florence Sotty, Poul Henning Jensen, et al.
Neurobiology of Disease|April 23, 2018
Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulationMichael Aagaard Andersen, Kenneth Vielsted Christensen, Lassina Badolo, et al.
British Journal of Pharmacology|January 17, 2016
Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivoFilippo Andreetta, Lucia Carboni, Gillian Grafton, et al.
Journal of Neurophysiology|September 23, 2016
α7-nAChR agonist enhances neural plasticity in the hippocampus via a GABAergic circuitMatthew Townsend, Andrew Whyment, Jean-Sebastien Walczak, et al.
Psychopharmacology|June 8, 2011
Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576Roberta Bursi, Gul Erdemli, Robert Campbell, et al.
The International Journal of Neuropsychopharmacology|October 10, 2013
Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer's diseaseEugene O'Hare, David I C Scopes, Eun-Mee Kim, et al.
Toxicology|January 9, 2018
PFE-360-induced LRRK2 inhibition induces reversible, non-adverse renal changes in ratsMichael Aagaard Andersen, Karen Malene Wegener, Steen Larsen, et al.
Acta Neuropathologica Communications|November 3, 2021
P62 accumulates through neuroanatomical circuits in response to tauopathy propagationFrançois-Xavier Blaudin de Thé, Benjamin Lassus, Ari W Schaler, et al.
Pageof 2